Tofacitinib Bioequivalence Study Comparing Tablets And Capsules
NCT01599377
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
tofacitinib 10 mg
DRUG:
tofacitinib 5 mg
Sponsor
Pfizer